Tyler Jacks, PhD, will step down from the Koch Institute for Integrative Cancer Research at MIT in Cambridge, Mass. after serving as director for over 19 years. Dr. Jacks will continue cancer genetics ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand down. Researchers at MIT and Stanford have now engineered a way to rip away ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we treat hundreds of genetic diseases. By fine-tuning the tiny molecular “tools ...